Novartis hopes Kisqali data will help narrow gap to blockbuster rival

Novartis has released data showing sharply improved overall survival rates for its breast cancer drug Kisqali, which the Swiss drugmaker hopes will help it ... Lees verder

Bron:

Pharmamarketeer